4 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
Follow sunitinib malate: new trials by email Literature Review of sunitinib malate trials Research Report on sunitinib malate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer sunitinib malate, sorafenib - Carcinoma, Hepatocellular | Phase 3 | Terminated | Pfizer | 1075 | 2008-07-01 | 2013-01-14 |
| A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors sunitinib malate, Placebo - Carcinoma, Islet Cell, Carcinoma, Pancreas | Phase 3 | Terminated | Pfizer | 171 | 2007-06-01 | 2010-10-11 |
| Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors sunitinib malate, imatinib mesylate - Gastrointestinal Stromal Tumor | Phase 3 | Terminated | Pfizer | 69 | 2007-06-01 | 2011-03-17 |
| A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine Capecitabine, Sunitinib malate - Breast Neoplasms | Phase 3 | Terminated | Pfizer | 482 | 2006-11-01 | 2012-06-25 |
Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Islet Cell (1) · Gastrointestinal Stromal Tumors (1) · Pancreatic Neoplasms (1)
Pfizer (4)
Germany (4) · Italy (4) · South Korea (4) · Spain (4) · United Kingdom (4) · Australia (3) · Canada (3) · France (3) · Hong Kong (3) · Taiwan (3) · United States (3) · Belgium (2) · Japan (2) · Philippines (2) · Singapore (2)
PMID 20203173, PMID 21306237, PMID 24081937, PMID 27836885, PMID 27924459, PMID 29161241, PMID 33411058, PMID 35226112